Showing 2071-2080 of 2788 results for "".
- New AAFPRS Data: More Than 30 Percent of Men Are Considering Nips and Tuckshttps://modernaesthetics.com/news/new-aafprs-data-more-than-30-percent-of-men-are-considering-nips-and-tucks/2472223/The plastic surgery ‘menaissaince’ may really be a thing, finds a new survey from the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS). It turns out that 31 percent of men said they are “extremely likely&rdq
- Read Their Lips: Avoid Unnatural Lip Enhancement Results With This Datahttps://modernaesthetics.com/news/read-their-lips-avoid-unnatural-lip-enhancement-results-with-this-data/2472247/Many a Real Housewife from Bravo’s hit reality TV franchise have been chastised for trout pout – or an overfilled, unnatural looking pucker. And now a new study, published by JAMA Facial
- Survey: Many Bothered By Double Chins, Take Steps To Cover Uphttps://modernaesthetics.com/news/survey-many-bothered-by-double-chins-take-steps-to-cover-up/2472259/Close to 50 percent of individuals are bothered by the appearance of the area under their chin, and many alter their behavior as a result, according to a new survey commissioned by Allergan plc.<
- Galderma Rolls Out Restylane Refyne, Defynehttps://modernaesthetics.com/news/galderma-rolls-out-restylane-refyne-defyne/2472262/With a growing number of hyaluronic acid (HA) fillers available and even more in the pike, Galderma is highlighting how their two newest fillers --
- FDA Approves Restylane Refyne and Restylane Defyne Dermal Fillers for “Laugh Lines”https://modernaesthetics.com/news/fda-approves-restylane-refyne-and-restylane-defyne-dermal-fillers-for-laugh-lines/2472303/The FDA has approved two new Galderma products for the treatment of nasolabial folds (NLF) or “laugh lines,” in patients over the age of 21. Restylane Refyne was approved for the treatment of moderate to severe facial wrinkles and folds and Restylane®
- BOTOX Cosmetic Names 2026 Confidence Collective Entrepreneur Cohorthttps://modernaesthetics.com/news/botox-cosmetic-names-2026-confidence-collective-entrepreneur-cohort/2487577/Allergan Aesthetics, an AbbVie company, has announced the 2026 cohort for The Confidence Collective: Empowering Women Entrepreneurs, a BOTOX® Cosmetic initiative designed to support women business owners through mentorship, education, and funding opportunities. According to the company, th
- Platelet-Rich Plasma May Function as a Bioregulatory System in Soft-Tissue Remodelinghttps://modernaesthetics.com/news/platelet-rich-plasma-may-function-as-a-bioregulatory-system-in-soft-tissue-remodeling/2487555/A newly published review in Aesthetic Plastic Surgery examines the evolving understanding of platelet-rich plasma (PRP), suggesting that its role in soft-tissue repair extends beyond conventional growth-factor delivery and may involve broader regulation of the tissue microenvironment.
- RRS® HA LONG LASTING Earns Top Skin Revitalization Honor at AMWC 2026https://modernaesthetics.com/news/rrs-ha-long-lasting-earns-top-skin-revitalization-honor-at-amwc-2026/2487529/Skin Tech Pharma Group announced that RRS® HA LONG LASTING has been awarded Best Injectable in the Skin Revitalization category at the AMWC Aesthetic Medicine Awards 2026, a recognition presented during the Aesthetic & Anti-Aging Medicine World Congress (AMWC). The award recognizes RRS
- Cellese Appoints Christopher Hausman as CEO to Lead Next Phase of Growth in Regenerative Aestheticshttps://modernaesthetics.com/news/cellese-appoints-christopher-hausman-as-ceo-to-lead-next-phase-of-growth-in-regenerative-aesthetics/2487520/Cellese Inc., the regenerative aesthetics company behind the AnteAGE® skincare brand, has appointed Christopher Hausman as Chief Executive Officer, the company announced. Hausman joins Irvine, California-based Cellese with more than 3 decades of experience in the aesthetics, skincare, dent
- FDA Approves SKINVIVE by JUVÉDERM® for Treatment of Horizontal Neck Lineshttps://modernaesthetics.com/news/fda-approves-skinvive-by-juvederm-for-treatment-of-horizontal-neck-lines/2487508/The US Food and Drug Administration (FDA) has approved SKINVIVE by JUVÉDERM® (Allergan Aesthetics, an AbbVie company) for the reduction of neck lines and improvement of neck appearance in adults aged 21 years and older, according to an announcement from the company. With the approval, SKIN